Surprisingly, we detected a significant increase in the percentage of CD4+PD1+CXCR5+FoxP3+ cTfr cells in both SLE patients and IRF5 risk carriers (Figure 3A,B, Supplementary Figure S1A,F). This evidence concerns the gene FOXP3 and systemic lupus erythematosus.